GEORGE B ABERCROMBIE Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for GEORGE B ABERCROMBIE.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of GEORGE B ABERCROMBIE. GEORGE B ABERCROMBIE is Director in BIOCRYST PHARMACEUTICALS INC ($BCRX) and CHIEF EXECUTIVE OFFICER in Brickell Biotech, Inc. ($VICL) and Sr. VP & Chief Comm. Officer in Innoviva, Inc. ($THRX) and Director in INSPIRE PHARMACEUTICALS INC ($ISPH).
Latest Insider Trading Transactions of GEORGE B ABERCROMBIE
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, BCRX, VICL, THRX, ISPH
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 12 2021 | BCRX | BIOCRYST PHARMACEU ... | ABERCROMBIE GEORGE B | Director | Sell | S | 12.70 | 7,000 | 88,900 | 3,000 | 10 K to 3 K (-70.00 %) |
| Feb 19 2020 | VICL | Brickell Biotech, ... | ABERCROMBIE GEORGE B | CHIEF EXECUTIVE OFF ... | Option Exercise | A | 1.16 | 8,764 | 10,166 | 8,764 | |
| Feb 19 2020 | VICL | Brickell Biotech, ... | ABERCROMBIE GEORGE B | CHIEF EXECUTIVE OFF ... | Option Exercise | A | 1.16 | 2,167 | 2,514 | 2,167 | |
| May 31 2019 | BCRX | BIOCRYST PHARMACEU ... | ABERCROMBIE GEORGE B | Director | Option Exercise | A | 2.91 | 30,000 | 87,300 | 30,000 | |
| Aug 22 2018 | THRX | Innoviva, Inc. | ABERCROMBIE GEORGE B | Sr. VP & Chief Comm ... | Sell | S | 14.11 | 8,000 | 112,840 | 285,479 | 293.5 K to 285.5 K (-2.73 %) |
| Aug 22 2018 | THRX | Innoviva, Inc. | ABERCROMBIE GEORGE B | Sr. VP & Chief Comm ... | Payment of Exercise | F | 14.08 | 5,680 | 79,974 | 293,479 | 299.2 K to 293.5 K (-1.90 %) |
| Jun 22 2018 | BCRX | BIOCRYST PHARMACEU ... | ABERCROMBIE GEORGE B | Director | Option Exercise | A | 6.09 | 30,000 | 182,700 | 30,000 | |
| May 22 2018 | THRX | Innoviva, Inc. | ABERCROMBIE GEORGE B | Sr. VP & Chief Comm ... | Sell | S | 14.40 | 8,000 | 115,202 | 299,159 | 307.2 K to 299.2 K (-2.60 %) |
| May 22 2018 | THRX | Innoviva, Inc. | ABERCROMBIE GEORGE B | Sr. VP & Chief Comm ... | Payment of Exercise | F | 14.59 | 4,682 | 68,310 | 305,235 | 309.9 K to 305.2 K (-1.51 %) |
| Mar 06 2018 | THRX | Innoviva, Inc. | ABERCROMBIE GEORGE B | Sr. VP & Chief Comm ... | Grant | A | 0.00 | 74,444 | 0 | 309,917 | 235.5 K to 309.9 K (+31.61 %) |
| Feb 22 2018 | THRX | Innoviva, Inc. | ABERCROMBIE GEORGE B | Sr. VP & Chief Comm ... | Sell | S | 16.51 | 8,000 | 132,100 | 235,473 | 243.5 K to 235.5 K (-3.29 %) |
| Feb 22 2018 | THRX | Innoviva, Inc. | ABERCROMBIE GEORGE B | Sr. VP & Chief Comm ... | Payment of Exercise | F | 16.44 | 15,500 | 254,820 | 243,473 | 259 K to 243.5 K (-5.99 %) |
| Nov 22 2017 | THRX | Innoviva, Inc. | ABERCROMBIE GEORGE B | Sr. VP & Chief Comm ... | Sell | S | 13.26 | 5,215 | 69,145 | 258,651 | 263.9 K to 258.7 K (-1.98 %) |
| Nov 22 2017 | THRX | Innoviva, Inc. | ABERCROMBIE GEORGE B | Sr. VP & Chief Comm ... | Payment of Exercise | F | 13.17 | 3,358 | 44,225 | 263,866 | 267.2 K to 263.9 K (-1.26 %) |
| Aug 22 2017 | THRX | Innoviva, Inc. | ABERCROMBIE GEORGE B | Sr. VP & Chief Comm ... | Payment of Exercise | F | 12.28 | 2,886 | 35,440 | 267,224 | 270.1 K to 267.2 K (-1.07 %) |
| May 25 2017 | BCRX | BIOCRYST PHARMACEU ... | ABERCROMBIE GEORGE B | Director | Option Exercise | A | 5.13 | 30,000 | 153,900 | 30,000 | |
| May 23 2017 | THRX | Innoviva, Inc. | ABERCROMBIE GEORGE B | Sr. VP & Chief Comm ... | Payment of Exercise | F | 11.86 | 2,228 | 26,424 | 270,110 | 272.3 K to 270.1 K (-0.82 %) |
| Feb 22 2017 | THRX | Innoviva, Inc. | ABERCROMBIE GEORGE B | Sr. VP & Chief Comm ... | Payment of Exercise | F | 12.04 | 5,355 | 64,474 | 269,838 | 275.2 K to 269.8 K (-1.95 %) |
| Jan 19 2017 | THRX | Innoviva, Inc. | ABERCROMBIE GEORGE B | Sr. VP & Chief Comm ... | Grant | A | 0.00 | 106,718 | 0 | 275,193 | 168.5 K to 275.2 K (+63.34 %) |
| Nov 22 2016 | THRX | Innoviva, Inc. | ABERCROMBIE GEORGE B | Sr. VP & Chief Comm ... | Payment of Exercise | F | 10.91 | 1,273 | 13,888 | 168,475 | 169.7 K to 168.5 K (-0.75 %) |
| Nov 22 2016 | THRX | Innoviva, Inc. | ABERCROMBIE GEORGE B | Sr. VP & Chief Comm ... | Payment of Exercise | F | 10.91 | 1,273 | 13,888 | 168,475 | 169.7 K to 168.5 K (-0.75 %) |
| Aug 23 2016 | THRX | Innoviva, Inc. | ABERCROMBIE GEORGE B | Sr. VP & Chief Comm ... | Payment of Exercise | F | 11.79 | 1,939 | 22,861 | 169,463 | 171.4 K to 169.5 K (-1.13 %) |
| May 25 2016 | BCRX | BIOCRYST PHARMACEU ... | ABERCROMBIE GEORGE B | Director | Option Exercise | A | 3.22 | 30,000 | 96,600 | 30,000 | |
| May 20 2016 | THRX | Innoviva, Inc. | ABERCROMBIE GEORGE B | Sr. VP & Chief Comm ... | Payment of Exercise | F | 11.09 | 1,276 | 14,151 | 171,402 | 172.7 K to 171.4 K (-0.74 %) |
| Feb 23 2016 | THRX | Innoviva, Inc. | ABERCROMBIE GEORGE B | Sr. VP & Chief Comm ... | Payment of Exercise | F | 12.28 | 5,376 | 66,017 | 170,178 | 175.6 K to 170.2 K (-3.06 %) |
| Jan 19 2016 | THRX | Innoviva, Inc. | ABERCROMBIE GEORGE B | Sr. VP & Chief Comm ... | Grant | A | 0.00 | 92,587 | 0 | 175,554 | 83 K to 175.6 K (+111.59 %) |
| May 22 2015 | BCRX | BIOCRYST PHARMACEU ... | ABERCROMBIE GEORGE B | Director | Option Exercise | A | 11.39 | 15,000 | 170,850 | 15,000 | |
| Jun 07 2010 | ISPH | INSPIRE PHARMACEUT ... | ABERCROMBIE GEORGE B | Director | Option Exercise | M | 0.00 | 1,592 | 0 | 0 | |
| Jun 07 2010 | ISPH | INSPIRE PHARMACEUT ... | ABERCROMBIE GEORGE B | Director | Option Exercise | A | 0.00 | 6,873 | 0 | 6,873 | |
| Jun 07 2010 | ISPH | INSPIRE PHARMACEUT ... | ABERCROMBIE GEORGE B | Director | Option Exercise | A | 5.82 | 10,164 | 59,154 | 10,164 | |
| Jun 07 2010 | ISPH | INSPIRE PHARMACEUT ... | ABERCROMBIE GEORGE B | Director | Payment of Exercise | F | 5.82 | 493 | 2,869 | 1,099 | 1.6 K to 1.1 K (-30.97 %) |
| Jun 07 2010 | ISPH | INSPIRE PHARMACEUT ... | ABERCROMBIE GEORGE B | Director | Buy | M | 0.00 | 1,592 | 0 | 1,592 | 0 to 1.6 K |
| Mar 02 2010 | ISPH | INSPIRE PHARMACEUT ... | ABERCROMBIE GEORGE B | Director | Option Exercise | A | 0.00 | 1,592 | 0 | 1,592 | |
| Mar 02 2010 | ISPH | INSPIRE PHARMACEUT ... | ABERCROMBIE GEORGE B | Director | Option Exercise | A | 0.00 | 12,739 | 0 | 12,739 | |
| Mar 02 2010 | ISPH | INSPIRE PHARMACEUT ... | ABERCROMBIE GEORGE B | Director | Option Exercise | A | 6.28 | 2,371 | 14,890 | 2,371 | |
| Mar 02 2010 | ISPH | INSPIRE PHARMACEUT ... | ABERCROMBIE GEORGE B | Director | Option Exercise | A | 6.28 | 18,970 | 119,132 | 18,970 | |
| Mar 02 2010 | ISPH | INSPIRE PHARMACEUT ... | ABERCROMBIE GEORGE B | Director | Option Exercise | A | 0.00 | 1,592 | 0 | 1,592 | |
| Mar 02 2010 | ISPH | INSPIRE PHARMACEUT ... | ABERCROMBIE GEORGE B | Director | Option Exercise | A | 0.00 | 12,739 | 0 | 12,739 | |
| Mar 02 2010 | ISPH | INSPIRE PHARMACEUT ... | ABERCROMBIE GEORGE B | Director | Option Exercise | A | 6.28 | 2,371 | 14,890 | 2,371 | |
| Mar 02 2010 | ISPH | INSPIRE PHARMACEUT ... | ABERCROMBIE GEORGE B | Director | Option Exercise | A | 6.28 | 18,970 | 119,132 | 18,970 |
Page: 1